(26 May 2021) Mycobacterium w-better clinical status distribution on days 14 and 21 compared to placebo
A randomised trial of Mycobacterium w in critically ill patients with COVID-19: ARMY-1 https://doi.org/10.1183/23120541.00059-2021 NCT04347174-Patients were randomised 1:1 to receive either 0.3 mL.day(-1) of Mw intradermally or a matching placebo for three consecutive days. The primary outcome of the study… Continue reading "(26 May 2021) Mycobacterium w-better clinical status distribution on days 14 and 21 compared to placebo"